While fibrosis grade distribution did not reach statistical significance (p = 0.394), clinically relevant patterns emerged: late-stage CKD patients had a 38% higher prevalence of moderate fibrosis (F2: 68.8% vs 50%) and nearly double the proportion of advanced fibrosis (F3-F4: 14.6% vs 25%).
← all excerpts
MAFLD in Egyptian non-dialysis CKD Patients: Frequency, fibrosis severity, and risk factors.
2
0.3940
0.3940
The sentences
HOMA-IR became borderline significant, implying insulin resistance’s impact is largely treatable with current therapies.